Viyash Scientific Clarifies Director Resignation Date Error
Viyash Scientific Limited clarified a date error in a previous filing. The resignation of Non-Executive Directors Dr. Fabian Kausche and Mr. Gregory Andrews, effective March 30, 2026, was incorrectly dated March 30, 2025, on the covering letter. The company has corrected this oversight.
The announcement is a correction of a typographical error in a date and does not involve any new material information regarding the company's operations, financials, or strategic direction.
The announcement is a factual clarification of a minor administrative error and does not contain any information that positively or negatively impacts the company's performance or outlook.
Viyash Scientific Limited (formerly Sequent Scientific Limited) has issued a clarification regarding a previous intimation submitted on March 30, 2026. The company stated that the date on the covering letter for the resignation of Non-Executive Directors, Dr. Fabian Kausche and Mr. Gregory Andrews, was inadvertently mentioned as March 30, 2025, instead of the correct date, March 30, 2026.
The resignations of Dr. Kausche and Mr. Andrews were effective from March 30, 2026.
The company has requested the stock exchanges to take note of this correction and has expressed regret for any inconvenience caused.
What to do with a filing like this
Viyash Scientific Limited filed this with the NSE as a statutory disclosure, categorised under board changes. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Viyash Scientific Limited. Read the original for the full detail.